(Q38937577)

7 September 2017

1 reference

title

The anti-Aspergillus drug pipeline: Is the glass half full or empty? (English)

1 reference

7 September 2017

author

Dimitrios P Kontoyiannis

series ordinal

2

object named as

Dimitrios P Kontoyiannis

1 reference

7 September 2017

Nir Osherov

1

1 reference

7 September 2017

language of work or name

1 reference

25 August 2016

1 reference

7 September 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Medical Mycology

1 reference

7 September 2017

volume

55

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

118-124

1 reference

Hidden killers: human fungal infections

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

"Is there an emerging need for new antifungals?".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Antifungal drug development: challenges, unmet clinical needs, and new approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Confronting the challenges of natural product-based antifungal discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Identification and characterization of a novel family of selective antifungal compounds (CANBEFs) that interfere with fungal protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

The Toxicity of a Novel Antifungal Compound Is Modulated by Endoplasmic Reticulum-Associated Protein Degradation Components

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

T-2307 causes collapse of mitochondrial membrane potential in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Uptake of T-2307, a novel arylamidine, in Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

T-2307, a novel arylamidine, is transported into Candida albicans by a high-affinity spermine and spermidine carrier regulated by Agp2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

In vitro and in vivo antifungal activities of T-2307, a novel arylamidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

In Vitro Activity of ASP2397 against Aspergillus Isolates with or without Acquired Azole Resistance Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Amphotericin B formulations and drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Novel Water-Soluble Amphotericin B-PEG Conjugates with Low Toxicity and Potent in Vivo Efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Nebulised amphotericin B-polymethacrylic acid nanoparticle prophylaxis prevents invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Antifungal drug discovery: the process and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Identification of a key lysine residue in heat shock protein 90 required for azole and echinocandin resistance in Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

In vitro activity of calcineurin and heat shock protein 90 Inhibitors against Aspergillus fumigatus azole- and echinocandin-resistant strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Combination of caspofungin with inhibitors of the calcineurin pathway attenuates growth in vitro in Aspergillus species

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Tacrolimus enhances the potency of posaconazole against Rhizopus oryzae in vitro and in an experimental model of mucormycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Disulphide-reduced psoriasin is a human apoptosis-inducing broad-spectrum fungicide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Biofilm Filtrates of Pseudomonas aeruginosa Strains Isolated from Cystic Fibrosis Patients Inhibit Preformed Aspergillus fumigatus Biofilms via Apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Hitting the caspofungin salvage pathway of human-pathogenic fungi with the novel lasso peptide humidimycin (MDN-0010).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Immunotherapy of Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Granulocyte transfusions in children and young adults: does the dose matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Granulocyte transfusion combined with granulocyte colony stimulating factor in severe infection patients with severe aplastic anemia: a single center experience from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

Activity, Reduced Toxicity, and Scale-Up Synthesis of Amphotericin B-Conjugated Polysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FMMY%2FMYW060

21 January 2018

Identifiers

DOI

10.1093/MMY/MYW060

1 reference

7 September 2017

1 reference